• Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-co...

• Lee Woo-Yul

• Oh Eun-Sil, Cui Mengqi, Kim Choon-Ok, Lim Ye-Ji, Kim Hu-Nam, Park Hyeon-Soo, Yoon Suk-Yong...

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 55 ~ 65

• Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained...

• Jin Xuanyou

• Kim Eun-Woo, Huh Ki-Young, Hwang In-Young, Cho Joo-Youn, Yu Kyung-Sang, Lee Seung-Hwan

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 43 ~ 54

• Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized th...

• Kim Woo-Young

• Kim Ho-Sook, Oh Min-Kyung, Shin Jae-Gook

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 34 ~ 42

• Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor

• Gu Nam-Yi

• Park Sang-In, Chung Hye-Won, Jin Xuanyou, Lee Seung-Hwan, Kim Tae-Eun

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 17 ~ 33

• Complex influences of gut microbiome metabolism on various drug responses

• Chae Si-Hyun

• Kim Da-Jung, Cho Joo-Youn

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 7 ~ 16

• What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian lo...

• Yum Sun-Young

• Translational and Clinical Pharmacology   2020  Volume.28  No.1 1 ~ 6